Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
ARK’s Cathie Wood Says Bitcoin’s Upsurge As Global Banks Roil Will Attract New Institutional Investors In Droves
-
Crawling Now, Sprinting Later: Analyst Foresees Major Bitcoin Rally
-
Teledyne Drops As Profit Outlook Comes In Below View
-
Crypto Analyst: ‘This Is Historically the Optimal Time To Allocate to Bitcoin’
-
ETF Analyst Bullish on US Spot Bitcoin ETF Success, Drawing from Canada’s 60% Growth